Biosimilars could disappear if the Supreme Court overturns the ACA

Stat News

1 April 2020 - With the sense of urgency rightly focused on slowing or stopping the spread of COVID-19, it seems like everything else in the news, and in health care, has come to a grinding halt. 

Yet important decision-making continues in the background, including some that could have long-lasting effects on health care today and in the future.

One of these is the decision by the U.S. Supreme Court to hear California v. Texas, a case that will decide whether most or all of the Affordable Care Act should be overturned.

Read Stat News article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Biosimilar